Key result
Early CMR established a diagnosis in 86% of patients with troponin-positive chest pain and non-obstructed arteries, with CMR diagnosis strongly predicting 4-year all-cause mortality (P<0.0001).
Why the study?
The study sought to assess the diagnostic and prognostic implications of early CMR, CMR-based deformation imaging, and conventional risk factors in patients presenting with troponin-positive acute chest pain and non-obstructed coronary arteries.
Does early cardiac magnetic resonance imaging provide diagnostic and prognostic value in patients with troponin-positive acute chest pain and non-obstructed coronary arteries?
Cohort (n=255)
Does early cardiac magnetic resonance imaging provide diagnostic and prognostic value in patients with troponin-positive acute chest pain and non-obstructed coronary arteries?
p-value: p=<0.0001
Early CMR successfully identifies the underlying etiology in 86% of patients with troponin-positive chest pain and non-obstructed coronary arteries, and strongly stratifies long-term mortality risk.
Supports early CMR for etiology and risk stratification in MINOCA; leaves open whether routine use improves outcomes in trials.
OBJECTIVE: We assessed the diagnostic and prognostic implications of early cardiac magnetic resonance (CMR), CMR-based deformation imaging and conventional risk factors in patients with troponin-positive acute chest pain and non-obstructed coronary arteries. METHODS: In total, 255 patients presenting between 2009 and 2019 with troponin-positive acute chest pain and non-obstructed coronary arteries who underwent CMR in ≤7 days were followed for a clinical endpoint of all-cause mortality. Cine movies, T2-weighted and late gadolinium-enhanced images were evaluated to establish a diagnosis of the underlying heart disease. Further CMR analysis, including left ventricular strain, was carried out. RESULTS: CMR (performed at a mean of 2.7 days) provided the diagnosis in 86% of patients (54% myocarditis, 22% myocardial infarction (MI) and 10% Takotsubo syndrome and myocardial contusion (n=1)). The 4-year mortality for a diagnosis of MI, myocarditis, Takotsubo and normal CMR patients was 10.2%, 1.6%, 27.3% and 0%, respectively. We found a strong association between CMR diagnosis and mortality (log-rank: 24, p<0.0001). Takotsubo and MI as the diagnosis, age, hypertension, diabetes, female sex, ejection fraction, stroke volume index and most of the investigated strain parameters were univariate predictors of mortality; however, in the multivariate analysis, only hypertension and circumferential mechanical dispersion measured by strain analysis were independent predictors of mortality. CONCLUSIONS: CMR performed in the early phase establishes the proper diagnosis in patients with troponin-positive acute chest pain and non-obstructed coronary arteries and provides additional prognostic factors. This may indicate that CMR could play an additional role in risk stratification in this patient population.
No takes yet. Share an insight, caveat, or question.
Vágó et al. (2020) conducted a cohort in Troponin-positive acute chest pain and non-obstructed coronary arteries (n=255). Early cardiac magnetic resonance (CMR) was evaluated on All-cause mortality (p=<0.0001). Early CMR established a diagnosis in 86% of patients with troponin-positive chest pain and non-obstructed arteries, with CMR diagnosis strongly predicting 4-year all-cause mortality (P<0.0001).
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: